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Until recemtbf a subcostal, StermotQmy QP tboracoto 
.Aessary to impiamt the r&es used in 
fibrillator systemts ( -3). al ~ammfa~tmr- 
ers are curremtly evaluating monthoracotomy lead systems 
two tramsvemo~s c&l electrodes that cam be used 
comjumction with a patch electrode placed sub- 
cutaneously om the left chest wall, Successful implamtatiom 
of these lectrode systems obviates theneed for thoracot- 
omy, thereby decreasing morbidity, reducin 
hospital lemgth of stay and potentially owering overall costs 
relative to thoracotomy4mplamted systems. At present, little 
is known about he factors contributing to he success or 
failure of cardioverter-defibrillator implantation using a 
momthoracotomy approach. These data would be helpful in 
plamnimg the implantation of such systems in individual 
patients. Hm the present study, B01 comsecutive patients 
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ring a ca~.rc8ioverter-deffbrilsator urn 
to, itnplamt a momtho~a~oto~y system were ~ros~e~tive~y 
determined. 
tiemts. A total of 101 consecutiv 
womea) were emtolled into this study 
underwent cardiac atheterization 
including echocardiography to deli 
abnormalities and left ventricular fum 
physiologic testing was performed 
dard techniques a previously desc 
imducible sustained ar 
arrhythmic drug t5al 
before cardioverter ~rnt~t~~m was at- 
tempted. Twenty-five patients (25%) were re~e~vim~ amtiar- 
rhythmic drugs at the tismc J ~~~~amtat~om ~ m~m~d~m~ or 
procainamide [m = 161, mexiletime [m= 3]? sotalol Em = 41 or 
amiodarone [m= 2]), All ~ardiove~er~d~~b~~~ator ianplamta- 
tions were perfornred as primary surgical procedures. 
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Tabk 1. Clinical Characteristics of the 101 Study Patients 
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6 of iO1 (61 
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19 e?’ 2; 13 to 22 
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0.54 L!z O.an; 0.44 to Q.69 
23 * 2; 18 to 29 
Dm pmzntcd mz mean value * SD at~d r-aqe OF number (81 of parients. 
CAM = coronary ar!ery bypass grail surgery; LVlD = ten ventriculur 
intcrnrl dimension. 
Patients were positioned on t 
access to the left chest within t
clavicular pocket was opened, 
Q anld connected to an externd ~~~~~~~~~t~rn~ 
device. Sensing and pacing ~~~$~~~~~ were 
nd were saGsfactory in ail cases. A stepwise 
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TWO EPICARDIAL PATCH ELECTRODES 
ONE TRAWENOU+S COIL ELECTRORE 
TWO EPICARDIAL PATCH ELECTRODES 
TWO TRANSVENOLJ: COIL ELECTRODES 
the patch was implante a lateral QF postero- 
tion on the chest supe 
he nQ~t~Qracotomy le 
a satjs~actory de~~ il~atiQ~ thresh pite testing rn~~ti~~e 
configurations, a left thoracotomy was performed with addi- 
tional testing after placement of one or more epicardial 
patches as outlined in Figure 1. The pulse generator was 
subsequently tested for appropriate arrbyt~mia detection 
and defibrillator function and implanted ina left paraumb~~- 
ical subcutaneous pocket. In all patiemts, a cudioverter- 
dcfibrihator system was implanted uring the same intra- 
operative session. Patients re uiring thoracotomy were 
admitted to the surgical in care unit postoperatively, 
but most patients with a racotomy implantation re- 
turned to a monitored med t bed after first going to the 
finitions and measwre ents. The defibrillation thrcsh- 
old was defined as the lowest energy level used to terminate 
ventricular fibrillation on three consecutive attempts. Car- 
diac size was defined as the maximal diameter ofthe cardiac 
silhouette measured on a posteroanterior chest X-ray film. 
Thoracic size was defined as the maximal transverse diam- 
eter of the thorax measured ona posteroanterior chest X-ray 
film and cardiothoracic ratio as the ratio of cardiac to 
thoracic size. The anteroposterior diameter was measured 
ou a left lateral chest X-ray projection from the inside border 
of the sternum to the inside border of the ribs at the level of 
the dome of the right diaphragm. Left ventricular ejection 
fraction was measured by gated blood pool scan or left 
ventriculography. The echocardiographic dimensions were 
standard measurements as reported previously by Sahn et al. 
(5). 
SD. Paired data were 
~rop~rt~o~s were analyzed by the 
model (4). Survival in the flonthoracotomy and t 
groups was compared with the use of life tab 
eviees. A 
nonthoracotomy system was successfully implanted in 72 
(71%) of 101 patients (Table 2). Seven different aonthora- 
cotomy configurations were used (Table a), with the most 
common configuration illustrated in Figure 2. 
of 101 patients required thoracotomy, many of whom also 
underwent testing using a higher defibrillating energy level. 
A total of seven different final thoracotomy configu 
were used, the most frequent 
“Rybrid” system as shown in 
patients, respective 
generator. Patients with a 
received one of three approv 
generators (Ventak MOO in = It& Ventak 1 
Ventak 1,555 [n= 61). All implant 
ered monophasic pulses. 
icatltrons were ob- 
within the 1st man 
hospital an4 have been followed up for a mean of 12 -C 7 
months (range 3 to 56) after implantation (Table 7). Seven 
patients (7%) died during the follow-up eriod (range 1.3 to 
6 months after implantation). The overaH actuarial survival 
rate at 1 year was 91 k 0.03% and did not differ between the 
two groups. A total of 30 patients (30%) received appropriate 
therapy for one or more arr ic episodes during the 
There are four main findings of our study. 1) Currently 
available nonthoracotomy cardioverter-defibrillator systems 
can be successfully implanted in >70% of patients who 
undergo this procedure as a first approach to treatment. 
2) The two nonthoracotomy systems evaluated ppear com- 
parable in their ability to defibrillate he heart. 3) Smaller 
cardiac size and female gender are the strongest positive 
predictors of successful nonthoracotomy implantation. 
4) The midterm outcome of patients with nonthoracotomy- 
and thoracotomy-implanted sy 
Success rate: of ~~~~bor~~~~~ ‘The results 
of our study are comparable to recent data pooled by the 
manufacturers (8) indicating success rates of 70% to 80%. 
Although our study group was not a consecutive s ries of 
patients undergoing cardioverter-defibrillator implantation, 
it does represent a typical series of patients wit 
tbr~at~~i~g ventricular rkythmias, serious cardiac disease 
and left ventricular dysfunction and is therefore similar to 
that in earlier series of patients u~dergo~mg “planned thora- 
cotomy” for ~ar~liovert~r-de~brj~lator impl;~~tatio~ (2,3,9- 
I I), Thus, the high success rate is not a reflection ofpatient 
selection with a ~re~o~dera~~e of patients at low risk, but 
rather is indicati~l~e of the true efficacy of these systems 
view is supported by our observation that 1 I (38%) of 
patients requiring thoracotomy required at least wo epicar- 
dial patches, and 6 of the 11 patients required three or more 
electrodes, including two epicardial patches. The ~ro~o~~o~ 
of patients with a high d~fibri~latiom br~~hold (225 J) was 
4%, which is similar’ to that described in most ““planned”’ 
thoracotomy series and suggests a $~rn~lar ~~~~tr~m of pa- 
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NS 
0,009 
NS 
NS 
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p Value 
w vs. C 
NS 
NS 
N% 
0.005 
NS 
success of dlefibrilbtion s probably a function of cardiac 
4s fE), In most cases of cardiac enl 
hem chamkrs uvolved and are mainly respons 
increased chest y cardiac size (13). 
enl ment is usually associated with 
thickness and heart w t wad is attributed to both yper- 
trophy and dilation ( Chapman etd. (12) previously 
V&Me Ctiac diieter (cm) 16.9 ” I.9 16.7 * 1.8 NS 
diametP”(cm) 31.1 I 2.5 31.3 22.7 NS 
0.54 t 0.06 0.54 f Q.06 NS 
between ventricular fibrillation asthe presenting arrhythmia 
and successful uonthoracotomy i plantation is probably 
ToMe 6. Complisations After Cantiaverter-Defibrillator 
Implantatian n 101 htknts 
Thoracotomy Nonthoracotomy Total 
(n = 29) (n = 72) (n = 101) 
SVC lead migradon 
Trip&r undersensing 
Trip&r high pacing threshold 
Tripohr lead retraction 
Tripolar lead perforation 
Trip~!a wzse~~irr~ 
Subcutaneous patch 
hematoma 
7 (11) 10 (10) 
Data presented are number (%) of patients. 
atn preselsted are ~~~~ber (%I of patieurs or rneau value -c SD. 
~sto~erat~ve recovery 
thoracotomy, who e 
treated with c~id~ra~ 
rativc days. Qn the basis of a ~ol~~arison 
of costs involving postoperative hospital Pength of stay, 
postoperative intensive care unit requirement and the need 
for epidural catheter insertion and maintenance, a minimal 
savings of $3,5Wpatient was realized in the nonthoracotomy 
patient group. 
Limitations of the study+ There are several potential 
limitations of our study. 1) The study groplp was relatively 
small and was not completely unselected. 2)Our study was 
performed with existing nonthoracotomy systems, incorpo- 
rating pulse generators with monophasic pulse waveforms. 
Recent studies (16,17) have shown that bi~~as~c shock 
forms can lower defibrillation e ergy requirements. Jt 
ely that newer systems utilizing biphasic waveforms 
will be successful in a higher percent of patients witch LI 
larger heart and that cardiac size itself might be less im- 
portant. 3) Because the transvenous leads were placed 
before the patient was taken to the operating room, adjust- 
unsuccess 
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